Table of Contents
What changed
Revenue was essentially flat at NZD 627.7m, down 0.3% on NZD 629.6m. Profit before tax fell 51.8% to NZD 24.0m and NPAT fell 55.5% to NZD 15.7m, a sharper decline because the effective tax rate rose to 34.7% from 29.3%. Operating cash flow fell 22.5% to NZD 62.0m, and capex stepped down to NZD 18.1m from NZD 26.5m, leaving pre-lease free cash flow of NZD 43.9m versus NZD 53.6m prior. Cash rose to NZD 32.3m but gross borrowings went to NZD 30.0m from NZD 12.5m, collapsing the net cash buffer to roughly NZD 2.3m from NZD 8.4m. The final dividend was cut to 3.0 cps from 3.5 cps. Segment mix shifted materially: Australia rose to 66.1% of revenue from 52.6%, Canada fell to 13.1% from 25.2%, and segment result margins compressed in all three regions — Australia to 6.8% from 16.2%, New Zealand to 9.3% from 19.4%, and Canada to 4.9% from 17.1%.
What matters
- Margin compression is broad, not localised. Every geographic segment posted a large margin contraction on broadly similar revenue, which points to input cost pressure and promotional clearance rather than a single-market problem. Gross margin settled at 60.6%, described as in line with guidance but weighed by higher input costs and promotional activity.
- The second half carried almost no earnings. HY24 contributed 98.2% of FY24 NPAT, implying about NZD 0.3m of net profit in H2 against NZD 15.4m in H1, despite H2 revenue of NZD 265.0m. That is the clearest signal of where trading deteriorated.
- Balance-sheet direction has weakened. Gross borrowings more than doubled, net cash shrank, ROE halved to 8.4% from 18.6%, and management has flagged a temporary NZD 40m facility uplift from 15 September 2024 to fund Christmas working capital — a proactive step but one that confirms seasonal funding needs have grown.
Expectations
No quantified FY25 guidance, forward order book or stated medium-term target was supplied. Management references a comparable EBIT figure of NZD 15.9m at the upper end of prior guidance and a 52-week revenue figure including Bevilles of NZD 644.9m, but the statutory result is what is verifiable here. The shape context shows H2 was materially weaker than H1 on earnings, so any FY25 read that assumes a normal seasonal skew would require H2-like margins to reverse — the release does not explicitly commit to that. Because PBT is the cleaner operating read given the tax rate distortion, the 51.8% PBT decline is the benchmark to improve against, not the 55.5% NPAT decline.
Quality of result
Earnings quality weakened on multiple fronts. The 55.5% NPAT fall overstates operating deterioration because of the higher effective tax rate, but the 51.8% PBT fall is itself severe on flat revenue. Cash conversion deteriorated: operating cash flow fell 22.5% while NPAT fell 55.5%, so OCF held up relatively better than earnings, but the absolute decline in OCF combined with lower capex is what protected pre-lease FCF. The dividend is covered by pre-lease FCF (payout ratio around 17%), but the payout ratio against NPAT rose to 47.7% from 38.0%, reflecting the earnings fall rather than a policy expansion. Inventories were essentially unchanged at NZD 203.7m despite management describing active clearance, so the margin cost of that clearance appears to have been absorbed into the P&L rather than a balance-sheet release.
Unresolved
- What is driving the uniform margin compression across Australia, New Zealand and Canada — input costs, discounting intensity, FX translation, or mix — and how much is structural versus cyclical?
- Why did H2 NPAT collapse to near zero relative to H1, and does that rate of trading persist into early FY25?
- How does the release reconcile statutory results with the "comparable EBIT of NZD 15.9m" and the 52-week revenue of NZD 644.9m including Bevilles? The full non-GAAP bridge was not fully extracted.
- How should the increased NZD 40m seasonal facility be interpreted against the longer-term funding structure once Christmas trade passes?
- Working-capital efficiency cannot be judged because trade debtor detail was not disclosed.
This briefing cannot assess the underlying like-for-like sales trajectory by geography, the FY25 trading update post year-end, or valuation, because those inputs were not supplied.
Key metrics
| Metric | FY24 | FY23 | Change |
|---|---|---|---|
| Revenue | $627.7m | $629.6m | -0.3% ↓ |
| EBITDA | — | $116.6m | — |
| Net profit after tax | $15.7m | $35.2m | -55.5% ↓ |
| Net cash inflow from operating activities | $62.0m | $80.1m | -22.5% ↓ |
| Final dividend per share | 3.0c | 3.5c | -14.3% ↓ |
| Operating profit | $30.4m | $58.9m | -48.3% ↓ |
| Profit before tax | $24.0m | $49.7m | -51.8% ↓ |
| Cash and cash equivalents | $32.3m | $20.9m | +54.7% ↑ |
| Total assets | $567.3m | $546.5m | +3.8% ↑ |
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Australia | $415.1m | $331.0m | $28.3m | +13.5pp |
| New Zealand | $130.5m | $132.4m | $12.2m | -0.2pp |
| Canada | $82.2m | $158.9m | $4.0m | -12.1pp |
Analytical metrics
| Metric | FY24 | FY23 | Context |
|---|---|---|---|
| PBT growth | -51.8% | — | cleaner earnings measure |
| Effective tax rate | 34.7% | 29.3% | — |
| FCF pre-lease | $43.9m | $53.6m | −$9.6m |
| FCF / NPAT | 280.4% | 152.4% | complementary conversion metric |
| Capex % revenue | 2.9% | 4.2% | — |
| Capex | −$18.1m | −$26.5m | +$8.4m |
| Net debt | −$2.3m | −$8.4m | +$6.1m |
| Gross borrowings | $30.0m | $12.5m | +$17.5m |
| Payout ratio vs NPAT | 47.7% | — | — |
| Payout ratio vs FCF pre-lease | 17.0% | — | covered |
| ROE (annualised) | 8.4% | 18.6% | Weakening |
| HY24 share of FY24 revenue | 57.8% | — | Other half was 42.2% |
| HY24 share of FY24 NPAT | 98.2% | — | Other half was 1.8% |
| Profit from continuing operations | $15.7m | $35.2m | −$19.5m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.